Cargando…

HDL and LDL have distinct, opposing effects on LPS-induced brain inflammation

Endotoxemia and sepsis induce neuroinflammation and increase the risk of neurodegenerative disorders although the mechanism by which peripheral infection leads to brain inflammation is not well understood. While circulating serum lipoproteins are known immunometabolites with the potential to modulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Radford-Smith, Daniel E., Yates, Abi G., Rizvi, Laila, Anthony, Daniel C., Probert, Fay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124044/
https://www.ncbi.nlm.nih.gov/pubmed/37095493
http://dx.doi.org/10.1186/s12944-023-01817-z
_version_ 1785029771785142272
author Radford-Smith, Daniel E.
Yates, Abi G.
Rizvi, Laila
Anthony, Daniel C.
Probert, Fay
author_facet Radford-Smith, Daniel E.
Yates, Abi G.
Rizvi, Laila
Anthony, Daniel C.
Probert, Fay
author_sort Radford-Smith, Daniel E.
collection PubMed
description Endotoxemia and sepsis induce neuroinflammation and increase the risk of neurodegenerative disorders although the mechanism by which peripheral infection leads to brain inflammation is not well understood. While circulating serum lipoproteins are known immunometabolites with the potential to modulate the acute phase response and cross the blood brain barrier, their contribution to neuroinflammation during systemic infection is unknown. The objective of this study was to elucidate the mechanisms by which lipoprotein subclasses modulate lipopolysaccharide (LPS)-induced neuroinflammation. Adult C57BL/6 mice were divided into 6 treatment groups, including a sterile saline vehicle control group (n = 9), an LPS group (n = 11), a premixed LPS + HDL group (n = 6), a premixed LPS + LDL group (n = 5), a HDL only group (n = 6) and an LDL only group (n = 3). In all cases injections were administered intraperitoneally. LPS was administered at 0.5 mg/kg, and lipoproteins were administered at 20 mg/kg. Behavioural testing and tissue collection was performed 6 h post-injection. The magnitude of peripheral and central inflammation was determined by qPCR of pro-inflammatory genes in fresh liver and brain. Metabolite profiles of liver, plasma and brain were determined by (1)H NMR. Endotoxin concentration in the brain was measured by the Limulus Amoebocyte Lysate (LAL) assay. Co-administration of LPS + HDL exacerbated both peripheral and central inflammation, whilst LPS + LDL attenuated this inflammation. Metabolomic analysis identified several metabolites significantly associated with LPS-induced inflammation, which were partially rescued by LDL, but not HDL. Endotoxin was detected at significantly greater concentrations in the brains of animals that received LPS + HDL compared to LPS + saline, but not those that received LPS + LDL. These results suggest that HDL may promote neuroinflammation through direct shuttling of endotoxin to the brain. In contrast, LDL was shown to have anti-neuroinflammatory properties in this study. Our results indicate that lipoproteins may be useful targets in neuroinflammation and neurodegeneration associated with endotoxemia and sepsis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-023-01817-z.
format Online
Article
Text
id pubmed-10124044
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101240442023-04-25 HDL and LDL have distinct, opposing effects on LPS-induced brain inflammation Radford-Smith, Daniel E. Yates, Abi G. Rizvi, Laila Anthony, Daniel C. Probert, Fay Lipids Health Dis Research Endotoxemia and sepsis induce neuroinflammation and increase the risk of neurodegenerative disorders although the mechanism by which peripheral infection leads to brain inflammation is not well understood. While circulating serum lipoproteins are known immunometabolites with the potential to modulate the acute phase response and cross the blood brain barrier, their contribution to neuroinflammation during systemic infection is unknown. The objective of this study was to elucidate the mechanisms by which lipoprotein subclasses modulate lipopolysaccharide (LPS)-induced neuroinflammation. Adult C57BL/6 mice were divided into 6 treatment groups, including a sterile saline vehicle control group (n = 9), an LPS group (n = 11), a premixed LPS + HDL group (n = 6), a premixed LPS + LDL group (n = 5), a HDL only group (n = 6) and an LDL only group (n = 3). In all cases injections were administered intraperitoneally. LPS was administered at 0.5 mg/kg, and lipoproteins were administered at 20 mg/kg. Behavioural testing and tissue collection was performed 6 h post-injection. The magnitude of peripheral and central inflammation was determined by qPCR of pro-inflammatory genes in fresh liver and brain. Metabolite profiles of liver, plasma and brain were determined by (1)H NMR. Endotoxin concentration in the brain was measured by the Limulus Amoebocyte Lysate (LAL) assay. Co-administration of LPS + HDL exacerbated both peripheral and central inflammation, whilst LPS + LDL attenuated this inflammation. Metabolomic analysis identified several metabolites significantly associated with LPS-induced inflammation, which were partially rescued by LDL, but not HDL. Endotoxin was detected at significantly greater concentrations in the brains of animals that received LPS + HDL compared to LPS + saline, but not those that received LPS + LDL. These results suggest that HDL may promote neuroinflammation through direct shuttling of endotoxin to the brain. In contrast, LDL was shown to have anti-neuroinflammatory properties in this study. Our results indicate that lipoproteins may be useful targets in neuroinflammation and neurodegeneration associated with endotoxemia and sepsis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-023-01817-z. BioMed Central 2023-04-24 /pmc/articles/PMC10124044/ /pubmed/37095493 http://dx.doi.org/10.1186/s12944-023-01817-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Radford-Smith, Daniel E.
Yates, Abi G.
Rizvi, Laila
Anthony, Daniel C.
Probert, Fay
HDL and LDL have distinct, opposing effects on LPS-induced brain inflammation
title HDL and LDL have distinct, opposing effects on LPS-induced brain inflammation
title_full HDL and LDL have distinct, opposing effects on LPS-induced brain inflammation
title_fullStr HDL and LDL have distinct, opposing effects on LPS-induced brain inflammation
title_full_unstemmed HDL and LDL have distinct, opposing effects on LPS-induced brain inflammation
title_short HDL and LDL have distinct, opposing effects on LPS-induced brain inflammation
title_sort hdl and ldl have distinct, opposing effects on lps-induced brain inflammation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124044/
https://www.ncbi.nlm.nih.gov/pubmed/37095493
http://dx.doi.org/10.1186/s12944-023-01817-z
work_keys_str_mv AT radfordsmithdaniele hdlandldlhavedistinctopposingeffectsonlpsinducedbraininflammation
AT yatesabig hdlandldlhavedistinctopposingeffectsonlpsinducedbraininflammation
AT rizvilaila hdlandldlhavedistinctopposingeffectsonlpsinducedbraininflammation
AT anthonydanielc hdlandldlhavedistinctopposingeffectsonlpsinducedbraininflammation
AT probertfay hdlandldlhavedistinctopposingeffectsonlpsinducedbraininflammation